The name Hims & Hers Health Inc. (HIMS) should be kept on your radar

In the latest session, Hims & Hers Health Inc. (NYSE: HIMS) closed at 5.47 down -3.70% from its previous closing price of $5.68. In other words, the price has decreased by $-0.21 from its previous closing price. On the day, 1183578 shares were traded. HIMS reached its highest trading level at $5.66 during the session, while it also had its lowest trading level at $5.34.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .



For a deeper understanding of Hims & Hers Health Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.80 and its Current Ratio is at 4.10. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on September 07, 2022, initiated with a Hold rating and assigned the stock a target price of $7.

On July 15, 2022, SVB Leerink started tracking the stock assigning a Underperform rating and target price of $4.

On April 14, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $10.Guggenheim initiated its Buy rating on April 14, 2022, with a $10 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 20 when Becklund Irene sold 10,668 shares for $5.68 per share. The transaction valued at 60,594 led to the insider holds 6,978 shares of the business.

O’Keefe Lynne Chou sold 10,046 shares of HIMS for $57,061 on Sep 20. The Director now owns 0 shares after completing the transaction at $5.68 per share. On Sep 09, another insider, Becklund Irene, who serves as the PAO of the company, sold 11,002 shares for $6.64 each. As a result, the insider received 73,053 and left with 2,715 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 3.11 while its Price-to-Book (P/B) ratio in mrq is 3.51.

Stock Price History:

Over the past 52 weeks, HIMS has reached a high of $9.19, while it has fallen to a 52-week low of $2.72. The 50-Day Moving Average of the stock is 6.20, while the 200-Day Moving Average is calculated to be 5.19.

Shares Statistics:

For the past three months, HIMS has traded an average of 1.94M shares per day and 1.2M over the past ten days. A total of 203.95M shares are outstanding, with a floating share count of 155.31M. Insiders hold about 0.80% of the company’s shares, while institutions hold 55.70% stake in the company. Shares short for HIMS as of Jul 14, 2022 were 12.31M with a Short Ratio of 6.88, compared to 9.28M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 5.97% and a Short% of Float of 10.22%.

Earnings Estimates

There are 6 different market analysts currently analyzing its stock. On average, analysts expect EPS of $-0.09 for the current quarter, with a high estimate of $-0.05 and a low estimate of $-0.11, while EPS last year was $-0.03. The consensus estimate for the next quarter is $-0.08, with high estimates of $-0.03 and low estimates of $-0.1.

Analysts are recommending an EPS of between $-0.16 and $-0.37 for the fiscal current year, implying an average EPS of $-0.32. EPS for the following year is $-0.28, with 6 analysts recommending between $-0.22 and $-0.36.

Revenue Estimates

A total of 8 analysts have provided revenue estimates for HIMS’s current fiscal year. The highest revenue estimate was $434.7M, while the lowest revenue estimate was $415.2M, resulting in an average revenue estimate of $422.77M. In the same quarter a year ago, actual revenue was $271.88M, up 55.50% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $527.02M in the next fiscal year. The high estimate is $564.55M and the low estimate is $499.07M. The average revenue growth estimate for next year is up 24.70% from the average revenue estimate for this year.